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o r i g i n a l a r t i c l e
Frequent Hospital Readmissions for Clostridium difficile Infection
and the Impact on Estimates of Hospital-Associated
C. difficile Burden
Courtney R. Murphy, MS;1 Taliser R. Avery, MSc;2 Erik R. Dubberke, MD, MSPH;3 Susan S. Huang, MD, MPH1
objective. Clostridium difficile infection (CDI) is associated with hospitalization and may cause readmission following admission for
any reason. We aimed to measure the incidence of readmissions due to CDI.
design. Retrospective cohort study.
patients. Adult inpatients in Orange County, California, who presented with new-onset CDI within 12 weeks of discharge.
methods. We assessed mandatory 2000–2007 hospital discharge data for trends in hospital-associated CDI (HA-CDI) incidence, with
and without inclusion of postdischarge CDI (PD-CDI) events resulting in rehospitalization within 12 weeks of discharge. We measured
the effect of including PD-CDI events on hospital-specific CDI incidence, a mandatory reporting measure in California, and on relative
hospital ranks by CDI incidence.
results. From 2000 to 2007, countywide hospital-onset CDI (HO-CDI) incidence increased from 15 per 10,000 to 22 per 10,000
admissions. When including PD-CDI events, HA-CDI incidence doubled (29 per 10,000 in 2000 and 52 per 10,000 in 2007). Overall,
including PD-CDI events resulted in significantly higher hospital-specific CDI incidence, although hospitals had disproportionate amounts
of HA-CDI occurring postdischarge. This resulted in substantial shifts in some hospitals’ rankings by CDI incidence. In multivariate models,
both HO and PD-CDI were associated with increasing age, higher length of stay, and select comorbidities. Race and Hispanic ethnicity
were predictive of PD-CDI but not HO-CDI.
conclusions. PD-CDI events associated with rehospitalization are increasingly common. The majority of HA-CDI cases may be
occurring postdischarge, raising important questions about both accurate reporting and effective prevention strategies. Some risk factors
for PD-CDI may be different than those for HO-CDI, allowing additional identification of high-risk groups before discharge.
Infect Control Hosp Epidemiol 2012;33(1):20-28
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Hospital length of stay has steadily decreased over the past
30 years,1 and increasingly, complex medical care is provided
after discharge through home health and skilled nursing fa-
cilities. In turn, adverse events related to hospitalization, in-
cluding hospital-associated infection, may increasingly be
present after discharge and result in readmission.2-5 The costs
and sequelae of hospital readmission have made it a target
for hospital quality indicators and value-based purchasing.6,7
Currently, the Centers for Medicare and Medicaid Services
reports hospitals’ rates of readmission following treatment
for myocardial infarction, congestive heart failure, and pneu-
monia, prompting a national focus on preventing readmis-
sion.8 However, readmission rates for other important con-
ditions, such as hospital-associated infections (HAIs), are not
well studied despite national and state requirements for re-
porting hospital-specific rates of HAIs.9-12
Clostridium difficile infection (CDI) is a common cause of
diarrhea in healthcare settings and may be an important
source of hospital readmissions.13-15 Hospital-associated C.
difficile acquisition may not be evident until after hospital
discharge, especially since the average hospital length of stay
is 3–5 days and acquisition may initially be asymptomatic.1,16
In addition, risk factors related to medical care, such as pre-
disposing antibiotics, may require time to deplete the normal
intestinal flora and allow C. difficile to flourish and produce
symptoms. The exact incubation period for CDI is unknown,
but 3 studies found the incubation period to be less than 1
week.22,23 However, several studies have found patients may
be at an increased risk for developing CDI up to 3 months
after hospital discharge.18-21 One recent study found that
among patients who developed CDI within 100 days post-
discharge, 89% of patients developed CDI in the first 60 days
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table 1. Characteristics of Hospital Inpatients, Orange County, California, 2000–2007
Characteristics of Hospital Admissions, N (%)
Characteristic All HO-CDI PD-CDI CA-CDI Total CDI
No. of patients N p 1,768,686 N p 1,952 N p 3,077 N p 5,667 N p 10,750
Male gender 675,111 (38) 919 (47) 1,213 (39) 2,416 (43) 4,580 (43)
Age, years
18–!40 497,982 (28) 146 (7) 194 (6) 364 (6) 703 (7)
40–49 220,320 (13) 164 (9) 218 (7) 443 (8) 819 (8)
50–59 220,859 (13) 243 (13) 255 (8) 596 (11) 1,105 (10)
60–!75 365,572 (21) 590 (31) 758 (25) 1,518 (28) 2,878 (28)
75 434,378 (25) 762 (40) 1,569 (52) 2,572 (47) 4,929 (47)
Race
White 1,419,979 (80) 1,582 (81) 2,698 (88) 4,775 (84) 9,103 (85)
Black 42,500 (3) 40 (2) 34 (1) 117 (2) 193 (2)
Asian 167,465 (9) 212 (11) 174 (6) 429 (8) 823 (7)
Other 138,761 (8) 118 (6) 171 (5) 346 (6) 631 (6)
Hispanic ethnicity 281,701 (16) 208 (11) 290 (9) 643 (11) 1,164 (11)
Romano score
0 880,857 (50) 349 (18) 704 (23) 1,203 (21) 2,120 (20)
1–2 407,651 (23) 405 (21) 750 (24) 1,187 (21) 2,275 (21)
3–4 221,440 (12) 397 (20) 621 (20) 1,068 (19) 2,110 (20)
5 258,757 (15) 801 (41) 1,002 (33) 2,209 (39) 4,245 (39)
Recent surgerya 570,445 (32) 869 (44) 986 (32) 1,143 (20) 2,848 (26)
note. HO-CDI, hospital-onset Clostridium difficile infection; PD-CDI, postdischarge CDI; and CA-CDI, community-
associated CDI.
a Recent surgery includes surgery during the current admission or within the previous 30 days.
and 85% occurred in the first month.17 To account for the
range of incubation period, national guidance considers CDI
occurring within 4 weeks of hospitalization as hospital as-
sociated, and CDI occurring within 4–12 weeks of a hospi-
talization as potentially hospital associated.22,23
Concerns about CDI have been increasing in the United
States. Hospitals’ incidence of CDI has been rising in the past
decade.24 This has been associated with the emergence of a
new epidemic strain, BI/NAP1/027, that produces 20-fold
more toxin than other strains and is associated with high
rates of colectomy and death.25-29 In fact, there is evidence in
some hospitals that CDI prevalence may have surpassed that
of methicillin-resistant Staphylococcus aureus (MRSA).30 With
continued pressure to reduce hospital length-of-stay, the fre-
quency of postdischarge CDI (PD-CDI)—defined here as
community-onset CDI within 12 weeks after any hospitali-
zation—may be increasing, along with the opportunity for
prevention.
In response to rising CDI incidence, the Centers for Disease
Control and Prevention (CDC) and the Society for Healthcare
Epidemiology of America (SHEA) have recommended sur-
veillance of healthcare-associated CDI (HA-CDI) rates, which
includes both hospital-onset as well as community-onset
healthcare-associated CDI.9,10 In addition, reporting of CDI
rates has been legislated or is under legislative consideration
in several states.31,32 Despite national guidance that postdis-
charge CDI events occurring within 4 weeks should be con-
sidered hospital associated and events between 4–12 weeks
of discharge could potentially be hospital associated, hospitals
performing CDI surveillance often do not track PD-CDI
events. However, tracking postdischarge events may facilitate
efforts to prevent readmissions and may be helpful for re-
porting hospital-specific CDI incidence. Moreover, patients
requiring readmission for PD-CDI may not return to the
original facility, suggesting that the incidence of HA-CDI may
be significantly underestimated if PD-CDI events are not uni-
formly identified among hospitals.14
We sought to identify CDI cases occurring at all hospitals
in a large California county (population 3 million). We as-
sessed the frequency of admission for new-onset CDI after a
recent hospitalization and the impact of including PD-CDI
events resulting in readmission on hospital-specific CDI in-
cidence.
methods
Description of Data Set
We conducted a population-based retrospective cohort study
to assess the frequency of postdischarge CDI events among
adult inpatients in all 29 hospitals serving adults in Orange
County, California, from January 1, 2000, to December 31,
2007. We used mandatory California hospital discharge data
which provides line-item demographic and insurer infor-
mation, ICD-9 codes (up to 25), and a unique identifier
(record linking number) that allows patients to be tracked
across hospital admissions.33 This data also includes a code
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figure 1. Clostridium difficile infection (CDI) burden among hospitalized adult patients in Orange County, California, from 2000 to 2007.
Incidence of hospital-onset CDI (HO-CDI), postdischarge CDI (PD-CDI), and hospital-associated CDI (HA-CDI) is expressed per 10,000
adult admissions; incidence of community-associated CDI (CA-CDI) is expressed per 100,000 Orange County adult population. HA-CDI
consists of HO-CDI and PD-CDI.
figure 2. Time to readmission for postdischarge Clostridium dif-
ficile infection cases (PD-CDI), 2000–2007, for cases occurring
within 1 year after discharge ( ).Np 1,766
to indicate whether a given condition was present when the
patient was admitted, known as the “present on admission”
(POA) code, which has been used in California since 1996.34
We identified CDI cases using the ICD-9 diagnostic code
008.45 for pseudomembranous colitis. We defined 4 types of
CDI cases: (1) hospital-onset CDI (HO-CDI) cases defined
by POA p N (no); (2) PD-CDI cases defined by POA p Y
(yes) with a history of hospitalization for any reason in the
prior 12 weeks; (3) HA-CDI cases defined as the sum of HO-
CDI and PD-CDI; and (4) community-associated CDI (CA-
CDI) cases defined by POA p Y with no prior history of
hospitalization in the previous 12 weeks. While we used 12
weeks for our primary analysis, we repeated all analyses using
a 4-week cutoff for comparison. To reduce the chance that
a code represented a past history of CDI without active in-
fection during hospitalization, we limited cases with POAp
Y to the first 3 coding positions. For POA p N cases, all
coding positions were accepted. We excluded 932 cases of
recurrent CDI, defined as cases occurring within 8 weeks of
a previous CDI episode.9,22 Finally, we assessed the fraction
of postdischarge events that occurred within 4 weeks of dis-
charge. This study was approved by the Institutional Review
Boards of the University of California Regents and the Cal-
ifornia Committee for the Protection of Human Subjects.
data analysis
Patient Characteristics
We collected demographic information for all patients in our
cohort, including gender, age, race and ethnicity, and insur-
ance type. We also assessed the proportion of hospitalized
patients with select comorbidities using the Romano score34
and the proportion that had undergone surgery in the pre-
vious month. These characteristics were collected for all ad-
missions and for those with CDI (HO-CDI, PD-CDI, and
CA-CDI).
Annual Incidence of CDI
Annual CDI incidence across Orange County was determined
for 2000–2007 and analyzed by x2 tests for trend. We iden-
tified all cases and subsets of CDI as defined above. Incidences
of HO-CDI, PD-CDI, and HA-CDI were expressed per 10,000
admissions. CA-CDI incidence was expressed per 100,000
residents.
Hospital Readmission for CDI
We defined a PD-CDI readmission as a case with symptoms
present on admission (POA p Y) that occurred within 12
weeks after a prior hospitalization for any reason, as described
above. We calculated the percentage of all-cause readmissions
that are due to PD-CDI. We excluded readmissions for re-
current CDI, which we defined as community-onset (POAp
Y) cases readmitted within 8 weeks of a previous admission
for CDI.22 We also determined how often patients readmitted
for PD-CDI went to a different facility for their readmission.
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figure 3. Hospital-specific rankings by hospital-associated Clos-
tridium difficile infection (HA-CDI) versus hospital-onset CDI (HO-
CDI) incidence for 2007. Shaded areas indicate the quartile of hos-
pitals with the highest CDI incidence based on HA-CDI versus
HO-CDI.
Impact of Including Postdischarge CDI Readmissions in
Hospital-Specific CDI Incidence
For each hospital, we determined the annual incidence of
HO-CDI and HA-CDI for the years 2000–2007. Differences
between annual HO-CDI and HA-CDI incidence were com-
pared using paired t tests. We determined whether relative
rankings by quartile of hospitals by CDI incidence were af-
fected by inclusion of PD-CDI.
Identifying Individual and Hospital Predictors of CDI
We identified the primary admission diagnoses of admissions
that were associated with HO-CDI and PD-CDI. For primary
admission diagnoses associated with greater than 25 HO-CDI
or PD-CDI events, we calculated the frequency of CDI com-
pared to those without that primary admission diagnosis.
We performed bivariate analyses using x2 tests to identify
individual and hospital level variables associated with the in-
dividual outcomes of HO-CDI and PD-CDI. For the PD-CDI
outcome, we used characteristics from the PD-CDI (vs the
index) admission and removed all hospitalizations that re-
sulted in death, since these hospitalizations could not result
in readmission. Individual variables included demographics,
comorbidities, primary admission diagnosis, recent surgery,
insurance type, year of hospital admission, and length of stay.
Hospital variables included annual admissions, average length
of stay, and hospital type (acute vs long-term acute care fa-
cility). Variables with from bivariate testing were en-P ! .1
tered into a generalized linear mixed model which accounted
for clustering by hospital (ProcGLIMMIX, SAS 9.2; SAS).
Variables were retained at .ap 0.05
results
Patient Characteristics
Patients admitted with CDI were older, had more comorbid-
ities, and were less likely to have undergone surgery in the
past month compared to all hospitalized patients (Table 1).
Among those with CDI, patients with HO-CDI and PD-CDI
had similar distributions of age, race and ethnicity, and co-
morbidities, but those with HO-CDI were more likely to be
male and to have undergone surgery in the past month.
Annual Incidence of HO-CDI and HA-CDI
Annual incidence of HO-CDI in Orange County increased
from 2000 to 2007, as shown in Figure 1 ( for testP ! .001
of trend). After including PD-CDI events, the annual inci-
dence of HA-CDI increased 1.9-fold during the same period,
from 28.7 to 52.2 per 10,000 admissions (x2, ). ByP ! .001
2007, PD-CDI comprised the majority of HA-CDI cases (in-
creasing from 46% in 2000 to 57% in 2007; for testP ! .001
of trend). Restricting PD-CDI cases to the 4 weeks following
discharge captured 73% of PD-CDI cases and resulted in
similar annual incidences of HA-CDI, increasing 1.8-fold
from 28.0 per 10,000 admissions in 2000 to 51.6 per 10,000
admissions in 2007 (x2, ).P ! .001
Frequency of New-Onset CDI as Reason for Hospital
Readmission
Over 2000–2007, PD-CDI events resulting in readmission
represented 1.8% (2,998 of 170,995) of all-cause readmissions
within 12 weeks after discharge. When evaluating all admis-
sions related to CDI occurring within 365 days of discharge,
we found that the risk of readmission for CDI was higher in
the first 12 weeks postdischarge, and highest in the first 4
weeks postdischarge (Figure 2). Of PD-CDI events occurring
within 12 weeks of discharge, 58% (624 of 1071) occurred
within the 4 weeks after discharge. After 12 weeks, the risk
of readmission for CDI dropped to a stable, low level. Among
PD-CDI cases readmitted within 12 weeks, 25% (746 of
2,998) were readmitted to a different hospital than the initial
hospitalization.
Impact of Including CDI Readmissions on Hospital-
Specific Rates
Figure 3 shows hospital-specific rankings according to CDI
incidence for 2007, with and without including PD-CDI
events (HO-CDI vs HA-CDI, respectively). The proportion
of hospitals’ HA-CDI comprised by PD-CDI varied greatly
(median 60% PD-CDI, range 0%–100%, for 2007). Hospital
ranking by CDI incidence changed by a mean of 3 places
after including PD-CDI events; only 5 of 29 hospitals did not
change rank. Three hospitals became ranked in the worst
quartile after including PD-CDI, including 1 hospital that
had been ranked in the best quartile when PD-CDI events
were excluded. Another 3 hospitals were no longer ranked
in the worst quartile when PD-CDI events were included.
When restricting PD-CDI events to 4 weeks postdischarge,
the proportion of HA-CDI comprised by PD-CDI similarly
varied from 0%–100% (median 46%). Hospital rankings
changed by a mean of 2.5 places, and 10 of 30 hospitals
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table 2. Frequent Primary Admission Diagnoses for Hospital Patients at High Risk for Clostridium difficile Infection
(CDI)
Primary admission diagnosis N (%) with HO-CDI OR P value N (%) with PD-CDI OR P value
Staphylococcus aureus septicemia 31 (0.6) 10.09 !.001 ... ...
S. aureus pneumonia 33 (0.7) 9.76 !.001 ... ...
Acute respiratory failure 117 (2.4) 8.56 !.001 31 (0.4) 1.22 .007
Aspiration pneumonitis 99 (2.1) 6.55 !.001 69 (0.8) 2.47 !.001
Infection of vascular device 33 (0.7) 6.16 !.001 26 (0.3) 2.65
Chemotherapy 30 (0.6) 5.43 !.001
E. coli septicemia 26 (0.5) 5.39 !.001 26 (0.3) 2.94 !.001
Septicemia 68 (1.4) 3.72 !.001 184 (1.2) 3.20 !.001
Postoperative infection 28 (0.6) 3.28 !.001 26 (0.3) 1.67 !.001
Acute renal failure 39 (0.8) 2.80 !.001 47 (0.5) 1.85 !.001
Pneumonia 98 (2.0) 1.69 !.001 184 (2.1) 1.74 !.001
Acute pancreatitis 31 (0.6) 1.51 .002 26 (0.3) 0.69 .8
Urinary tract infection 37 (0.8) 1.43 .19 96 (1.1) 2.04 !.001
Hip fracture ... ... 31 (0.4) 1.76 !.001
Cellulitis ... ... 45 (0.5) 1.69 !.001
Colon diverticulitis ... ... 45 (0.5) 1.68 !.001
note. HO-CDI, hospital-onset CDI; PD-CDI, postdischarge CDI; OR, odds ratio.
changed quartile. Nine hospitals did not change rank; these
hospitals all had zero CDI events.
Identifying Individual and Hospital Predictors of CDI
Primary admission diagnoses that occurred most often during
HO-CDI and PD-CDI admissions are listed in Table 2. Several
primary admission diagnoses were significantly associated
with both HO-CDI and PD-CDI admissions on bivariate
analysis, including septicemia, pneumonia, postoperative in-
fection, and urinary tract infection.
Results from bivariate analysis (Table 3) were similar to those
from multivariate analysis (Table 4). In multivariate analysis,
HO-CDI and PD-CDI were both associated with increasing
age, longer length of stay, Medicare insurance, recent surgery,
comorbidities, select primary admission diagnoses (septicemia,
postoperative infection, and pneumonia), and hospitals with
a high percent of patients with a high comorbidity index. Non-
white race, Hispanic ethnicity, and male gender were protective
against PD-CDI but not HO-CDI.
Annual Incidence of Community-Associated CDI
Orange County’s incidence of CA-CDI also rose during 2000
to 2007. In this period, CA-CDI incidence increased 2.1-fold
from 9.1 to 19.4 cases per 100,000 residents (x2, ),P ! .001
exclusive of PD-CDI cases. These rates were similar when
PD-CDI was restricted to events within 4 weeks of discharge
(9.5 to 19.8 cases per 100,000 residents; x2, ).P ! .001
discussion
Clostridium difficile disease is a major cause of healthcare-
associated infection and morbidity. Due to the known delay
in presentation following antibiotic exposure, national guide-
lines consider cases up to 12 weeks following hospital dis-
charge as potentially healthcare-associated and possibly pre-
ventable. Nevertheless, the majority of hospitals do not track
postdischarge cases, and the impact of postdischarge cases
has remained largely unknown. Remarkably, we found that
PD-CDI cases within 12 weeks after hospital discharge ac-
counted for the majority of HA-CDI and led to a 2-fold
increase in HA-CDI incidence across hospitals in a large met-
ropolitan county. These effects were largely driven by PD-
CDI events within 4 weeks after hospital discharge. This find-
ing illustrates the need to expand prevention and education
strategies to include the postdischarge period and thereby
reduce the frequency of PD-CDI events.
Inclusion of postdischarge CDI events substantially altered
hospital-specific CDI incidence, but the impact varied widely
by hospital. For example, PD-CDI cases accounted for all
HA-CDI cases in one hospital and none of the cases in an-
other. This suggests that tracking PD-CDI events may impact
the validity of interfacility comparisons, since hospitals are
affected differentially by including or excluding PD-CDI.
These discrepancies could be magnified if only some, but not
all, hospitals track PD-CDI. When we ranked hospitals by
HO-CDI incidence, half the hospitals captured in the quartile
with the highest HO-CDI incidence changed when PD-CDI
was included. In fact, one hospital changed from the best
quartile to the worst quartile when PD-CDI cases were cap-
tured. Further, changes in rank were similar when PD-CDI
was restricted to events within 4 weeks postdischarge, with
one-third of hospitals changing quartile after inclusion of PD-
CDI. In addition, since 75% of patients with PD-CDI re-
turned to the same hospital for readmission, hospitals may
be able to track most PD-CDI cases by performing postdis-
charge surveillance for PD-CDI cases that readmit to their
own facility. Additional notification of PD-CDI cases back to
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table 3. Bivariate Analysis of Predictors of Hospital-Onset Clostridium difficile Infection (HO-CDI) and Postdischarge CDI
(PD-CDI) Among All Adult Inpatients
Individual variables (%) HO-CDI Non-HO-CDI P value PD-CDI Non-PD-CDI P value
N 2,403 1,766,753 3,077 1,725,165
Age, years !.001 !.001
18–!40 6.7 28.7 6.5 29.3
40–49 7.8 12.7 7.3 12.8
50–59 11.9 12.7 8.5 12.8
60–!75 31.7 21.0 25.3 20.9
75 41.9 24.9 52.4 24.2
Male gender 48.2 38.2 !.001 39.4 37.9 .08
Race .01 !.001
White 80.9 80.3 87.7 80.2
Black 2.2 2.4 1.1 2.4
Asian 10.6 9.5 5.6 9.5
Other 6.3 7.8 5.6 7.9
Hispanic ethnicity 11.1 16.2 !.001 9.5 16.4 !.001
Medicare insurance 36.8 59.8 !.001 29.9 60.6 !.001
Medicaid insurance 92.0 89.5 !.001 95.2 89.4 !.001
Admit to acute hospital (vs LTAC)a 87.2 96.8 !.001 96.3 96.8 .08
Admission year !.001 !.001
2000 10.2 11.7 7.9 11.6
2001 10.6 12.2 9.1 12.2
2002 11.7 12.4 9.6 12.4
2003 10.8 12.9 10.9 12.9
2004 11.8 12.7 12.2 12.7
2005 13.5 12.7 16.3 12.7
2006 16.3 12.5 17.6 12.6
2007 15.1 12.9 16.4 12.9
Length of stay 15 days 96.7 27.4 !.001 56.2 26.8 !.001
Surgeryb 42.3 32.2 !.001 25.7 30.5 !.001
Comorbidities
Diabetes 29.6 16.9 !.001 24.7 16.6 !.001
Cancer 15.1 7.8 !.001 13.5 7.5 !.001
Dementia 5.9 2.9 !.001 5.8 2.8 !.001
Ulcer 4.6 1.8 !.001 2.7 1.7 !.001
AIDS 0.6 0.2 !.001 0.4 0.2 .02
High comorbidity indexc 64.5 27.1 !.001 52.8 26.0 !.001
Admitted to high-volume hospitald 61.9 61.1 !.001 72.2 67.2 !.001
Admitted to hospital with high length of staye 85.4 77.2 !.001 71.5 77.1 !.001
note. Data other than N and P shown as percentage. AIDS, acquired immune deficiency syndrome.
a LTAC, long-term acute care facility.
b Surgery indicates surgery during the current admission or within the previous 30 days.
c Comorbidity index measured by Romano score.
d High volume, 110,000 annual admissions.
e High length of stay, 15 days.
transferring or recently discharging hospitals may also im-
prove accuracy of CDI rates.
For prevention, patient characteristics may be utilized to
identify populations at elevated risk for postdischarge CDI.
We found that risk factors for HO-CDI and PD-CDI were
often the same, including increasing age, higher length of
stay, and overall poor health, including diabetes, cancer, and
AIDS, in agreement with prior studies.24 In addition, pre-
vention may be targeted at patients with specific primary
admission diagnoses such as septicemia, postoperative infec-
tion, and pneumonia. These primary admission diagnoses all
represent conditions likely to be treated with antibiotics, the
main risk factor for CDI. The immediate postdischarge period
should be considered an extension of the risk of CDI that
begins during a hospital stay. This heightens the importance
of educating high-risk patients before hospital discharge
about the potential for postdischarge diarrhea and of iden-
tifying prophylactic solutions to prevent disease in the high-
risk patient population.
In addition, we found that white and non-Hispanic patients
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table 4. Multivariate Analysis of Predictors of Hospital-Onset Clostridium difficile Infection





Individual variables OR (95% CI) P value OR (95% CI) P value
Age, years !.001 !.001
18–!40 Reference Reference
40–49 1.93 (1.29–2.89) 2.20 (1.53–3.17)
50–59 1.82 (1.23–2.71) 2.21 (1.54–3.17)
60–!75 1.83 (1.28–2.61) 2.76 (1.99–3.82)
75 2.16 (1.51–3.09) 3.93 (2.85–5.44)
Male gender 1.04 (0.93–1.16) .49 0.87 (0.80–0.95) .001
Race .01 !.001
White Reference Reference
Black 0.94 (0.61–1.45) 0.49 (0.31–0.78)
Asian 1.27 (1.06–1.52) 0.64 (0.53–0.77)
Other 0.79 (0.59–1.05) 1.04 (0.85–1.28)
Hispanic ethnicity 0.94 (0.77–1.15) .56 0.73 (0.62–.86) !.001
Medicare insurance 0.61 (0.48–.77) !.001 0.70 (0.56–.87) .001
Admission year 1.07 (1.05–1.09) !.001 1.11 (1.09–1.13) !.001
2000 (reference)
2001 1.03 (0.81–1.33) 0.92 (0.75–0.86)
2002 1.12 (0.88–1.43) 1.04 (0.86–1.27)
2003 0.94 (0.73–1.21) 1.14 (0.94–1.38)
2004 1.22 (0.96–1.55) 1.35 (1.12–1.62)
2005 1.25 (0.99–1.58) 1.67 (1.40–1.99)
2006 1.55 (1.24–1.94) 1.83 (1.53–2.18)
2007 1.39 (1.10–1.74) 1.71 (1.43–2.04)
Length of stay 1.02 (1.02–1.02) !.001 1.01 (1.01–1.01) !.001
Surgerya 2.16 (1.91–2.43) !.001 1.23 (1.12–1.35) !.001
Comorbidities
Diabetes 1.36 (1.20–1.53) !.001 1.14 (1.03–1.25) .009
Cancer 1.32 (1.13–1.55) !.001 1.24 (1.09–1.42) .001
Dementia 1.57 (1.28–1.93) !.001 1.03 (0.87–1.21) .74
Ulcer 1.92 (1.49–2.47) !.001 1.31 (1.04–1.67) .02
AIDS 4.15 (2.02–8.50) !.001 3.27 (1.60–6.65) .001
High comorbidity indexb 1.06 (1.02–1.11) !.001 1.02 (1.01–1.03) .001
Primary admission diagnosis
Chemotherapy 7.08 (4.04–12.42) !.001 ...
Staphylococcus aureus pneumonia 5.13 (3.23–8.16) !.001 ...
Infection due to vascular device 3.05 (1.87–4.97) !.001 ...
Septicemia 2.70 (3.71–1.96) !.001 3.55 (2.87–4.40) !.001
Postoperative infection 2.36 (3.89–1.43) !.001 2.39 (1.51–3.76) !.001
Acute respiratory failure 2.25 (1.63–3.10) !.001 ...
Pneumonia 1.47 (1.93–1.11) .006 1.82 (1.54–2.16) !.001
Cellulitis ... 2.41 (1.72–3.38) !.001
Colon diverticulitis ... 2.37 (1.64–3.43) !.001
Urinary tract infection ... 1.86 (1.48–2.33) !.001
Acute renal failure ... 1.73 (1.25–2.39) !.001
note. CI, confidence interval; OR, odds ratio.
a Surgery indicates surgery during the current admission or within the previous 30 days.
b Comorbidity index measured by Romano score.
had a higher risk of PD-CDI. While we did not evaluate
reasons for this difference, racial and ethnic disparities, in-
cluding access to health care, have been well documented and
may be magnified in the outpatient arena.36,37 Differences in
access to outpatient care are likely to impact antibiotic use
in these groups and their subsequent risk of PD-CDI. In
addition, male gender was associated with lower risk of PD-
CDI but not with HO-CDI. This difference may not be due
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to an increased postdischarge risk for women but may instead
reflect men’s reduced tendency to seek care and therefore be
hospitalized for PD-CDI.38,39 More research is needed to un-
derstand the reasons for differential risk in these groups in
order to develop effective prevention strategies for the post-
discharge setting.
Our study has several limitations. We did not capture PD-
CDI cases treated in the outpatient setting, which may have
led to an underestimate of PD-CDI incidence. Nevertheless,
the focus on PD-CDI associated with rehospitalization en-
sured capture of the most serious cases. While errors present
in administrative data may lead to an under- or overesti-
mation of CDI incidence, previous studies indicate reasonable
agreement between medical records and ICD-9 codes for
identification of total CDI burden.40,41 Nevertheless, without
POA codes, ICD-9 codes alone have been variably successful
at distinguishing between community versus healthcare-
associated C. difficile disease.42 We anticipate that the POA
code, which has been in standard use in California for over
a decade, improves this determination. In fact, POA codes
have proven useful in other diseases (pneumonia, myocardial
infarction) for distinguishing between hospital versus com-
munity-onset disease.43 We also minimized the chances that
a code represented a history of CDI only versus active disease
by limiting diagnoses to the first 3 coded positions. Another
limitation is that we did not account for certain known risk
factors (such as antibiotic use) that were unavailable in ad-
ministrative data. However, we included primary admission
diagnoses that are frequently treated with antibiotics. Finally,
we attributed a PD-CDI event to the most recent hospitali-
zation within 12 weeks. This definition does not account for
multiple hospital exposures during that period or for inter-
vening nursing home admissions, which may also contribute
to CDI acquisition. Further, since the incubation period for
CDI is unknown, some cases occurring within our 12-week
window may be due to exposures in the community, includ-
ing outpatient antibiotic use, household pets, and contami-
nation of food. Nonetheless, over half of PD-CDI cases de-
tected in this study occurred within the first 4 weeks after
discharge, a time window that is accepted by national guid-
ance to most likely reflect healthcare-associated CDI events.
In summary, tracking PD-CDI cases doubled the incidence
of HA-CDI in a large county. Since the majority of hospitals
do not track PD-CDI cases, the frequency and impact of PD-
CDI may be widely underestimated, resulting in missed op-
portunities to prevent readmissions. Importantly for public
reporting purposes, including PD-CDI affected individual hos-
pitals differently, leading to substantial changes in hospital
rankings by CDI incidence. Uniform tracking of PD-CDI
events would allow more accurate estimates of overall CDI
incidence and more equitable hospital-to-hospital compari-
sons. We found that the vast majority of cases can be captured
if hospitals track PD-CDI cases that return to the same facility.
We also identified several patient characteristics that were as-
sociated with PD-CDI, suggesting that preventative strategies
may effectively focus upon specific patient groups. Targeted
education and prevention for CDI may become increasingly
important to help hospitals lower their readmission rates.
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